Literature DB >> 14630806

Immunodeficiency virus uptake, turnover, and 2-phase transfer in human dendritic cells.

Stuart G Turville1, John J Santos, Ines Frank, Paul U Cameron, John Wilkinson, Monica Miranda-Saksena, Joanne Dable, Hella Stössel, Nikolaus Romani, Michael Piatak, Jeffrey D Lifson, Melissa Pope, Anthony L Cunningham.   

Abstract

HIV-1 subverts antigen processing in dendritic cells (DCs) resulting in viral uptake, infection, and transfer to T cells. Although DCs bound monomeric gp120 and HIV-1 similarly, virus rarely colocalized with endolysosomal markers, unlike gp120, suggesting HIV-1 alters endolysosomal trafficking. Virus within DC intracellular compartments rapidly moved to DC-CD4+ lymphocyte synapses when introduced to CD4+ lymphocyte cultures. Although viral harboring and transfer from nonlysosomal compartments was transient, given DC-associated virus protein, nucleic acids, and infectious HIV-1 transfer to CD4+, lymphocytes decayed within 24 hours. However a second long-term transfer phase was apparent in immature DCs after 48 hours as a zidovudine-sensitive rise in proviral DNA. Therefore, DCs transfer HIV-1 to CD4+ lymphocytes in 2 distinct phases. Immature and mature DCs first divert virus from the endolysosomal pathway to the DC-T-cell synapse. Secondly, the later transfer phase from immature DCs is through de novo HIV-1 production. Thus, the controversy of DCs being infected or not infected for the mechanics of viral transfer to CD4+ lymphocytes can be addressed as a function of time.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14630806     DOI: 10.1182/blood-2003-09-3129

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  195 in total

1.  Saquinavir inhibits early events associated with establishment of HIV-1 infection: potential role for protease inhibitors in prevention.

Authors:  Martha Stefanidou; Carolina Herrera; Naomi Armanasco; Robin J Shattock
Journal:  Antimicrob Agents Chemother       Date:  2012-06-04       Impact factor: 5.191

2.  Human immunodeficiency virus-1 inhibition of immunoamphisomes in dendritic cells impairs early innate and adaptive immune responses.

Authors:  Fabien P Blanchet; Arnaud Moris; Damjan S Nikolic; Martin Lehmann; Sylvain Cardinaud; Romaine Stalder; Eduardo Garcia; Christina Dinkins; Florence Leuba; Li Wu; Olivier Schwartz; Vojo Deretic; Vincent Piguet
Journal:  Immunity       Date:  2010-05-06       Impact factor: 31.745

Review 3.  Dangerous liaisons at the virological synapse.

Authors:  Vincent Piguet; Quentin Sattentau
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

4.  HIV-1 exploits innate signaling by TLR8 and DC-SIGN for productive infection of dendritic cells.

Authors:  Sonja I Gringhuis; Michiel van der Vlist; Linda M van den Berg; Jeroen den Dunnen; Manja Litjens; Teunis B H Geijtenbeek
Journal:  Nat Immunol       Date:  2010-04-04       Impact factor: 25.606

5.  3D visualization of HIV transfer at the virological synapse between dendritic cells and T cells.

Authors:  Richard L Felts; Kedar Narayan; Jacob D Estes; Dan Shi; Charles M Trubey; Jing Fu; Lisa M Hartnell; Gordon T Ruthel; Douglas K Schneider; Kunio Nagashima; Julian W Bess; Sina Bavari; Bradley C Lowekamp; Donald Bliss; Jeffrey D Lifson; Sriram Subramaniam
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-12       Impact factor: 11.205

6.  Mucosal and systemic anti-HIV immunity controlled by A20 in mouse dendritic cells.

Authors:  Bangxing Hong; Xiao-Tong Song; Lisa Rollins; Lindsey Berry; Xue F Huang; Si-Yi Chen
Journal:  J Clin Invest       Date:  2011-01-04       Impact factor: 14.808

7.  HIV-1 N-glycan composition governs a balance between dendritic cell-mediated viral transmission and antigen presentation.

Authors:  Thijs van Montfort; Dirk Eggink; Maikel Boot; Michael Tuen; Catarina E Hioe; Ben Berkhout; Rogier W Sanders
Journal:  J Immunol       Date:  2011-09-28       Impact factor: 5.422

8.  Site-specific labeling of enveloped viruses with quantum dots for single virus tracking.

Authors:  Kye-Il Joo; Yuning Lei; Chi-Lin Lee; Jonathon Lo; Jiansong Xie; Sarah F Hamm-Alvarez; Pin Wang
Journal:  ACS Nano       Date:  2008-08       Impact factor: 15.881

9.  Impaired accessory cell function in a human dendritic cell line after human immunodeficiency virus infection.

Authors:  Prarthana Beuria; Houchu Chen; Michael Timoney; Kirk Sperber
Journal:  Clin Diagn Lab Immunol       Date:  2005-03

10.  Maturation of blood-derived dendritic cells enhances human immunodeficiency virus type 1 capture and transmission.

Authors:  Nuria Izquierdo-Useros; Julià Blanco; Itziar Erkizia; Maria Teresa Fernández-Figueras; Francesc E Borràs; Mar Naranjo-Gómez; Margarita Bofill; Lidia Ruiz; Bonaventura Clotet; Javier Martinez-Picado
Journal:  J Virol       Date:  2007-05-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.